Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
Mineralys Therapeutics, Inc. (MLYS)
Levy Adam Scott — CFO and Secretary
Shares
10,758
Price
$32.14
Total Value
$345.72K
Shares Held After
8,638
% of Holdings
55.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$32.32
Total Value
$205.14K
Shares Held After
61,804
% of Holdings
9.3%
Zymeworks Inc. (ZYME)
Hollywood Mark — EVP & Chief Operating Officer
Shares
6,120
Price
$22.67
Total Value
$138.76K
Shares Held After
132,913
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$479.51
Total Value
$3.78M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$479.51
Total Value
$7.01M
Shares Held After
0
% of Holdings
100.0%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
13,165
Price
$37.43
Total Value
$492.77K
Shares Held After
140,769
% of Holdings
8.6%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
20,533
Price
$37.43
Total Value
$768.55K
Shares Held After
154,514
% of Holdings
11.7%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
36,932
Price
$37.43
Total Value
$1.38M
Shares Held After
350,919
% of Holdings
9.5%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
13,548
Price
$37.43
Total Value
$507.10K
Shares Held After
184,174
% of Holdings
6.9%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
27,289
Price
$37.43
Total Value
$1.02M
Shares Held After
579,394
% of Holdings
4.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
66,610
Price
$37.43
Total Value
$2.49M
Shares Held After
1,037,528
% of Holdings
6.0%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
11,047
Price
$37.43
Total Value
$413.49K
Shares Held After
156,700
% of Holdings
6.6%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
21,142
Price
$37.43
Total Value
$791.35K
Shares Held After
176,883
% of Holdings
10.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
315
Price
$174.86
Total Value
$55.08K
Shares Held After
306,891
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
297
Price
$172.36
Total Value
$51.19K
Shares Held After
307,206
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
297
Price
$171.31
Total Value
$50.88K
Shares Held After
307,503
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
160
Price
$170.24
Total Value
$27.24K
Shares Held After
307,800
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
6,996
Price
$169.57
Total Value
$1.19M
Shares Held After
307,960
% of Holdings
2.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,176
Price
$168.63
Total Value
$1.21M
Shares Held After
314,956
% of Holdings
2.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,974
Price
$167.73
Total Value
$666.56K
Shares Held After
322,132
% of Holdings
1.2%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
6,131
Price
$64.15
Total Value
$393.29K
Shares Held After
37,068
% of Holdings
14.2%
Zymeworks Inc. (ZYME)
Smith Jeffrey T L — EVP & Chief Medical Officer
Shares
9,310
Price
$22.67
Total Value
$211.09K
Shares Held After
26,708
% of Holdings
25.8%
Zymeworks Inc. (ZYME)
Moore Paul Andrew — Chief Scientific Officer
Shares
9,560
Price
$22.67
Total Value
$216.76K
Shares Held After
48,497
% of Holdings
16.5%
Aktis Oncology, Inc. (AKTS)
EcoR1 Capital, LLC — Director
Shares
144,443
Price
$18.00
Total Value
$2.60M
Shares Held After
347,305
% of Holdings
41.6%
Aktis Oncology, Inc. (AKTS)
EcoR1 Capital, LLC — Director
Shares
2,077,779
Price
$18.00
Total Value
$37.40M
Shares Held After
4,348,658
% of Holdings
47.8%
Zymeworks Inc. (ZYME)
Galbraith Kenneth — Director
Shares
30,424
Price
$22.67
Total Value
$689.82K
Shares Held After
226,842
% of Holdings
11.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
8,548
Price
$1.71
Total Value
$14.66K
Shares Held After
83,800
% of Holdings
9.3%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
5,388
Price
$1.73
Total Value
$9.31K
Shares Held After
593,510
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,024
Price
$78.70
Total Value
$80.59K
Shares Held After
80,141
% of Holdings
1.3%
Aktis Oncology, Inc. (AKTS)
Vida Ventures II, LLC — 10% Owner
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Aktis Oncology, Inc. (AKTS)
Vida Ventures II, LLC — 10% Owner
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
58,980
Price
$0.57
Total Value
$33.62K
Shares Held After
2,309,869
% of Holdings
2.5%
Aktis Oncology, Inc. (AKTS)
Kim Helen Susan — Director
Shares
22,545
Price
$18.00
Total Value
$405.81K
Shares Held After
157,387
% of Holdings
14.3%
Aktis Oncology, Inc. (AKTS)
Kim Helen Susan — Director
Shares
812,455
Price
$18.00
Total Value
$14.62M
Shares Held After
5,671,825
% of Holdings
14.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
32,705
Price
$5.50
Total Value
$179.88K
Shares Held After
708,587
% of Holdings
4.4%
Palisade Bio, Inc. (PALI)
Williams Donald Allen — Director
Shares
5,000
Price
$1.88
Total Value
$9.40K
Shares Held After
5,728
% of Holdings
87.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$33.27
Total Value
$72.20K
Shares Held After
61,804
% of Holdings
3.4%
Alumis Inc. Common Stock (ALMS)
AKKARAJU SRINIVAS — Director
Shares
588,235
Price
$17.00
Total Value
$10.00M
Shares Held After
1,853,488
% of Holdings
31.7%
Enliven Therapeutics, Inc. (ELVN)
Patel Anish — CHIEF OPERATING OFFICER
Shares
243
Price
$28.50
Total Value
$6.93K
Shares Held After
215,011
% of Holdings
0.1%
Enliven Therapeutics, Inc. (ELVN)
Patel Anish — CHIEF OPERATING OFFICER
Shares
48,057
Price
$27.98
Total Value
$1.34M
Shares Held After
215,254
% of Holdings
18.3%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$40.78
Total Value
$815.63K
Shares Held After
60,000
% of Holdings
25.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
280
Price
$551.24
Total Value
$154.35K
Shares Held After
187,164
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
40
Price
$545.79
Total Value
$21.83K
Shares Held After
187,164
% of Holdings
0.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
600
Price
$540.36
Total Value
$324.21K
Shares Held After
187,204
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
480
Price
$539.23
Total Value
$258.83K
Shares Held After
187,804
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
80
Price
$537.85
Total Value
$43.03K
Shares Held After
188,284
% of Holdings
0.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
487
Price
$536.88
Total Value
$261.46K
Shares Held After
188,364
% of Holdings
0.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
473
Price
$536.02
Total Value
$253.54K
Shares Held After
188,851
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
148
Price
$535.29
Total Value
$79.22K
Shares Held After
189,324
% of Holdings
0.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
FRIEDMAN PAUL A — Director
Shares
332
Price
$534.16
Total Value
$177.34K
Shares Held After
189,472
% of Holdings
0.2%
Showing 2601–2650 of 3515 transactions (page 53 of 71)